IGF2BP2 and acute lymphoblastic leukemia: Another paper explores targeting IGF2BP2 in T-cell acute lymphoblastic leukemia (T-ALL), revealing its role in promoting cell proliferation and impairing chemotherapy sensitivity by stabilizing NOTCH1 mRNA.